Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center

Autor: Igor Kozak, Andres F. Lasave, Vishali Gupta, J. Fernando Arevalo, Hassan A Al Dhibi, Mosa Barakat Al Harbi, Abdulaziz Adel Al Rushood
Rok vydání: 2015
Předmět:
Vogt–Koyanagi–Harada disease
Adult
Male
medicine.medical_specialty
Visual acuity
genetic structures
Adolescent
Prednisolone
Visual Acuity
Glaucoma
Administration
Oral

Tertiary Care Centers
03 medical and health sciences
0302 clinical medicine
Prednisone
Recurrence
Chart review
Ophthalmology
medicine
Immunology and Allergy
Humans
Fluorescein Angiography
Child
Antibiotics
Antitubercular

Glucocorticoids
Aged
Retrospective Studies
030203 arthritis & rheumatology
business.industry
Panuveitis
Exudative retinal detachment
Middle Aged
Mycophenolic Acid
medicine.disease
eye diseases
Treatment Outcome
Acute Disease
Chronic Disease
030221 ophthalmology & optometry
Drug Therapy
Combination

Female
sense organs
medicine.symptom
business
Uveomeningoencephalitic Syndrome
Uveitis
Tomography
Optical Coherence

medicine.drug
Zdroj: Ocular immunology and inflammation. 24(5)
ISSN: 1744-5078
Popis: Purpose: To describe the clinical characteristics and treatment outcomes of Vogt–Koyanagi–Harada (VKH) disease over a 12-year period.Methods: A retrospective chart review was used to identify VKH patients, from January 1999 to December 2011.Results: In total, 154 patients (308 eyes) were diagnosed with VKH. The mean age at diagnosis was 33.8 ± 13 years. Mean baseline best-corrected visual acuity (BCVA) was 20/125; (0.8 ± 0.6 logMAR). Recurrent episodes occurred in 107 (54%) patients. Oral prednisone was administered in all patients. At the last visit, the mean BCVA was 20/50 (0.4 ± 0.7 logMAR). The most common complications post-treatment were: glaucoma [104 (33.8%) eyes] and cataract [84 (27.2%) eyes].Conclusions: In Saudi Arabia, VKH-related uveitis is predominant in young females. Bilateral panuveitis is the most common ocular manifestation and near 50% of eyes present with exudative retinal detachment. Oral prednisone was the primary treatment and the majority of eyes maintained 20/50 or bette...
Databáze: OpenAIRE